ID: ALA574529
Chembl Id: CHEMBL574529
PubChem CID: 45481636
Max Phase: Preclinical
Molecular Formula: C9H16N2O8P2
Molecular Weight: 342.18
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1ccn(CCCCCP(=O)(O)OP(=O)(O)O)c(=O)[nH]1
Standard InChI: InChI=1S/C9H16N2O8P2/c12-8-4-6-11(9(13)10-8)5-2-1-3-7-20(14,15)19-21(16,17)18/h4,6H,1-3,5,7H2,(H,14,15)(H,10,12,13)(H2,16,17,18)
Standard InChI Key: DWPOJFJAWGVQKN-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 342.18 | Molecular Weight (Monoisotopic): 342.0382 | AlogP: 0.00 | #Rotatable Bonds: 8 |
| Polar Surface Area: 158.92 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
| #RO5 Violations: ┄ | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 1.91 | CX Basic pKa: ┄ | CX LogP: -0.98 | CX LogD: -5.79 |
| Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.38 | Np Likeness Score: -0.09 |
| 1. Sauer R, El-Tayeb A, Kaulich M, Müller CE.. (2009) Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists., 17 (14): [PMID:19523835] [10.1016/j.bmc.2009.05.062] |
Source(1):
